Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: A 10-year prospective study

Blood

Volumn 90, Issue 9, 1997, Pages 3799-3805

  Locasciulli, Anna ^a   Testa, Marina ^b   Valsecchi, Maria Grazia ^b   Vecchi, Laura ^b   Longoni, Daniela ^b   Sparano, Paola ^b   Rovelli, Attilio ^b   Uderzo, Cornelio ^b   Masera, Giuseppe ^b   Alberti, Alfredo ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; HEPATITIS B SURFACE ANTIGEN; MELPHALAN; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHRONIC LIVER DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEPATITIS B; HEPATITIS C; HUMAN; INFANT; LIVER FAILURE; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION;

EID: 0030871212     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3799     Document Type: Article

References (27)

1. Locasciulli A, Alberti A, De Bock R, Cordonnier C, Einsele H, Engelhard D, Grundy J, Reusser P, Ribaud P, Ljungman P: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: A survey from the European Bone Marrow Transplantation (EBMT) Group-Infectious Diseases Working Party. Bone Marrow Transplant 14:833, 1994
2. McDonald GB, Shulman HM, Spencer GD: Liver disease after human marrow transplant. Semin Liver Dis 7:210,1987
3. Azar N, Valla D, Abdel-Samad I, Hoang C, Fretz C, Sutton L, Fournel JJ, Le Charpentier Y, Binet JL, Leblond V: Liver disfunction in allogeneic bone marrow transplantation recipients. Transplantation 62:56, 1996
4. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Benaji M, Hardin BJ, Shulman HM, Clift RA: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 118:255, 1993
5. Frickhofen N, Wiesneth M, Jainta C, Hertenstein B, Heymer B, Bianchi L, Dienes HP, Koerner K, Bunjes D, Arnold R, Kubanek B, Heimpel H: Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood 83:1998, 1994
6. Locasciulli A, Bacigalupo A, Alberti A, VanLint MT, Uderzo C, Marmont AM,Shulman HM, Portmann B: Predictability before transplant of hepatic complications following allogeneic bone marrow transplantation. Transplantation 48:68, 1989
7. Erer B, Angelucci E, Lucarelli G, Giardini C, Barociani D, Galimberti M, Polchi P, Amadei G, Battistini L, Paolucci S, Gaziev D: Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 14:369, 1994
8. Ljungman P, Johansson N, Aschan J, Glaumann H, Lonnqvist B, Ringdén O, Sparrelid E, Sonnerborg A, Winiarski J, Gahrton G: Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 86:1614,1995
9. Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C: Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: Incidence, risk factors, and clinical outcome. Bone Marrow Transplant 7:467, 1991
10. Méresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L, Lemerle J: Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: A study in 136 children. Bone Marrow Transplant 10:135, 1992.
11. Storb R, Deeg HJ, Whithaed J, Appelbaum FR, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Whiterspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
12. Locasciulli A, Bacigalupo A, VanLint MT, Cavalletto D, Pontisso P, Testa M, Masera G, Shulman HM, Portmann B, Alberti A: Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 16:407, 1995
13. Tisminetzky S, Gerotto M, Pontisso P, Chemello L, Baralle F, Alberti A: Genotype of hepatitis C virus in Italian patients with chronic hepatitis C. Int Hepatol Communications 2:103, 1994
14. Jones RJ, Lee KSK, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbrenner LL, Santos GW, Saral L: Venocclusive disease of the liver following bone marrow transplantation. Transplantation 44:778, 1987
15. Styler MJ, Crilley P, Biggs J, Moul J, Copelan E, Topolsky D, Avalos B, Penza S, Sabol P, Downs K, Szer J, Brodsky I, Marks DI: Hepatic dysfunction following busulfan and cyclophosphamide myeloablation:A retrospective, multicenter analysis. Bone Marrow Transplant 18:171, 1996
16. Rozman C, Carreras E, Qian C, Gale RP, Bortin MM, Rowlings PA, Ash RC, Champlin RE, Henslee-Downey PJ, Herzig RH, Hinterberger W, Klein JP, Prentice HG, Reiffers J, Zwann FE, Horowitz MM: Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 17:75, 1996
17. Brugieres L, Hartmann O, Benhamou E, Zafrani ES, Caillaud JM, Patte C, Kalifa C, Flamant F, Lemerle J: Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: Incidence, clinical course and outcome. Bone Marrow Transplant 3:53, 1987
18. Mateos ML, Camarero C, Maldonado S, Lasa E, Otheo E, Munoz A: Antibodies to hepatitis C virus in human immunoglobulins: Clinical meaning and diagnostic difficulties in children undergoing bone marrow transplant. Bone Marrow Transplant 14:95, 1994
19. Ganem G, Saint-Marc Girardin MF, Kuentz M, Cordonnier C, Marinello G, Teboul C, Braconnier F, Vernant JP, Dhumeaux D, Le Bourgeois JP: Venoocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Rad Oncol Biol Phys 14:879, 1988
20. Dix SP, Wingard JR, Mullins RE, Jerkunica I, Davidson TG, Gilmore CE, York RC, Lin LS, Devine SM, Geller RB, Heffner LT, Hillyer CD, Holland HK, Winton EF, Saral R: Association of Busulfan under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant 17:225, 1996
21. Bearman SI: The syndrome of hepatic veno-occlusive disease after bone marrow transplantation. Blood 85:3005, 1995
22. Alberti A, Chemello L, Cavalletto D, Tagger A, dal Canton A, Bizzarre N, Tagariello G, Ruol A: Antibody to hepatitis C virus and liver disease in volunteer blood donors. Ann Intern Med 114:1010, 1991
23. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH: A long-term study of hepatitis C virus replication in nonA, nonB hepatitis. N Engl J Med 325:98,1991
24. Locasciulli A, Bacigalupo A, VanLint MT, Tagger A, Uderzo C, Portmann B, Shulman HM, Alberti A: Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 52:315, 1991
25. Locasciulli A, Bacigalupo A, VanLint MT, Chemello I, Pontisso P, Occhini D, Uderzo C, Shulman HM, Portmann B, Marmont AM, Alberti A: Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: A report of 30 cases. Bone Marrow Transplant 6:25, 1990
26. Chen PM, Fan S, Liu CJ, Hsieh RK, Liu JH, Chuang MW, Liu RS, Tzeng CH: Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 49:708,1990
27. Ilan Y, Nagler A, Adler R, Naparstek E, Or R, Slavin S, Brautbar C, Shouval D: Adoptive transfer of immunity to hepatitis B virus after T cell depleted allogeneic bone marrow transplantation. Hepatology 18:246, 1993